AliveCor QT Service vs Autoplaque

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by AliveCor
VS
by APQ Health (formerly Cedars-Sinai Medical Center: AIM)

AI Verdict

Tool A specializes in electrophysiology, providing instant QT and QTc interval measurements from ECGs to assess cardiac safety and guide medication prescribing. In contrast, Tool B focuses on structural heart disease, offering quantitative analysis of coronary plaques and luminal stenoses from CT angiography images for heart attack risk prediction. While both contribute to cardiology, they address different clinical needs with distinct data inputs and analytical approaches.

Choose AliveCor QT Service if…

Choose AliveCor QT Service if you need instant, accurate QT and QTc interval measurements from ambulatory ECGs to assess cardiac safety, particularly when monitoring for potential drug-induced QT prolongation. This cloud-based SaMD is ideal for healthcare professionals making timely medication prescribing decisions where immediate cardiac electrical activity assessment is critical.

View AliveCor QT Service →

Choose Autoplaque if…

Choose Autoplaque if you require detailed, AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. This workstation-based software is best suited for clinicians focused on comprehensive heart attack risk prediction and guiding treatment strategies based on precise anatomical characterization of atherosclerotic disease.

View Autoplaque →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AliveCor QT Service Autoplaque
Pricing Varies by product and service, with subscription options available. Unknown
Deployment Mobile app, cloud-based platform, EHR integration. Workstation-based post-processing application, runs on Windows or Mac OS.
BAA Available Yes AI-estimated Unknown
FDA Status 1 AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AliveCor QT Service

AliveCor QT Service (Tool A) is cloud-based and integrates with existing apps and portals, offering an 'InstantQT' feature for rapid results. This deployment model and integration capability suggest a more accessible and streamlined user experience compared to Autoplaque's (Tool B) workstation-based software, which may require dedicated hardware and local management.

Clinical Value

Tie

Both tools are FDA-cleared and address critical, distinct clinical needs in cardiology. AliveCor QT Service (Tool A) provides essential cardiac safety assessments related to medication, while Autoplaque (Tool B) offers quantitative analysis for heart attack risk prediction and treatment guidance. Their respective clinical contributions are significant and equally valuable in different aspects of patient care.

Pricing & Value

Tie

Neither AliveCor QT Service (Tool A) nor Autoplaque (Tool B) disclose their pricing details, requiring direct contact with the vendor. Without transparent pricing information, it is impossible to conduct a comparative assessment of their cost-effectiveness or overall value proposition.

Enterprise Readiness

AliveCor QT Service

AliveCor QT Service (Tool A) demonstrates strong enterprise readiness with its cloud-based deployment, explicit HIPAA compliance, availability of Business Associate Agreements (BAA), and extensive API for integration with EHR and other healthcare platforms. Autoplaque (Tool B) is workstation-based and does not specify HIPAA compliance or BAA availability, making it less clearly suited for large-scale enterprise deployment.

Innovation

Tie

Both tools showcase significant innovation by leveraging AI and deep neural networks to solve complex problems in cardiology. AliveCor QT Service (Tool A) innovates with instant QT/QTc measurements from mobile ECGs, while Autoplaque (Tool B) provides advanced quantitative analysis of coronary plaques from CT angiography, both pushing the boundaries of diagnostic capabilities.

Support & Docs

AliveCor QT Service

AliveCor QT Service (Tool A) offers a comprehensive and publicly accessible support ecosystem, including a dedicated support portal, FAQs, user manuals, and direct contact options. In contrast, Autoplaque (Tool B) provides no readily apparent public support resources or extensive documentation beyond an implied user manual, based on available information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AliveCor QT Service Autoplaque
Name AliveCor QT Service Autoplaque
Company AliveCor Cedars-Sinai Medical Center: AIM
Description A cloud-based Software as a Medical Device (SaMD) that provides instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs, enabling healthcare professionals to assess cardiac safety and inform medication prescribing decisions. Autoplaque, developed by Cedars-Sinai AIM, is an FDA-cleared AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance.
Categories Cardiology AI, Pharmacology & Dosing AI Cardiology AI, Radiology & Imaging AI
Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology, Radiology
Key Features Cloud-based Software as a Medical Device (SaMD); Measures QT and QTc intervals (Bazett's and Fridericia's formulas); Analyzes ECGs from AliveCor 6-Lead ambulatory ECG devices (e.g., KardiaMobile 6L); Prescription (Rx) use only, for qualified healthcare professionals; Utilizes AI and deep neural networks for ECG analysis; Provides instant QT measurements (as InstantQT); Integrates with KardiaStation app and KardiaPro portal; API available for integration with EHR, SDK, CRM, EDC, and PSP platforms AI-powered quantitative analysis of atherosclerotic plaque; Detection and characterization of coronary artery plaque; Measurement of luminal stenoses; Analysis of coronary anatomy and pathology from CT Angiographic images; Workstation-based post-processing application; Automated vessel, plaque, and lumen segmentation (reviewable and editable by clinician); Review of heart and coronary vessels in Multiplanar Reformatting (MPR), curved MPR, and straightened MPR views; Measurement of vessel diameter and area

Videos

Demos, reviews, and walkthroughs featuring AliveCor QT Service and Autoplaque.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AliveCor QT Service is primarily used for instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs, enabling healthcare professionals to assess cardiac safety and inform medication prescribing decisions. Autoplaque focuses on quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance.
AliveCor QT Service analyzes electrocardiograms (ECGs) from AliveCor 6-Lead ambulatory ECG devices, such as the KardiaMobile 6L. Autoplaque performs analysis on coronary CT angiography images.
AliveCor QT Service utilizes AI and deep neural networks to measure QT and QTc intervals (Bazett's and Fridericia's formulas) from ECGs. Autoplaque provides AI-powered quantitative analysis for the detection, characterization, and measurement of atherosclerotic plaque and luminal stenoses from CT angiographic images, including automated vessel, plaque, and lumen segmentation.
AliveCor QT Service integrates with the KardiaStation app and KardiaPro portal, and offers an API for integration with EHR, SDK, CRM, EDC, and PSP platforms. Autoplaque is described as a workstation-based post-processing application, with no explicit API or EHR integration details provided in the facts.
AliveCor QT Service focuses on cardiac safety by providing QT and QTc interval measurements, which are crucial for assessing the risk of arrhythmias like Torsades de Pointes, especially when prescribing QT-prolonging medications. Autoplaque addresses heart attack risk prediction and treatment guidance through quantitative analysis of coronary atherosclerotic plaque and luminal stenoses from CT angiography images.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.